Vivos Inc. (RDGL) News
Follow Vivos Inc. (RDGL) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 2 public stories across 2 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Vivos Inc. announces peer-reviewed PrecisionGel™ polymer platform paper
Vivos Inc. (OTCQB: RDGL) said a peer-reviewed paper describing its PrecisionGel™ thermogel polymer platform was published in Elsevier’s Journal of Drug Delivery Science and Technology.
EQUITY | Sep 03, 2026, 12:08 PM UTC
L
Vivos Inc. (OTCQB: RDGL) Receives U.S. FDA Approval for Investigational Device Exemption (IDE) to Initiate Human Clinical Feasibility Study
Kennewick, WA, July 06, 2026 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL
EQUITY | Jul 06, 2026, 12:30 PM UTC